About the Authors

Kishore Viswanathan

Contributed equally to this work with: Kishore Viswanathan, Kathleen M. Frey

Affiliation Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut, United States of America

Kathleen M. Frey

Contributed equally to this work with: Kishore Viswanathan, Kathleen M. Frey

Affiliation Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut, United States of America

Eric W. Scocchera

Affiliation Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut, United States of America

Brooke D. Martin

Affiliation Promiliad Biopharma Inc., Alberton, Montana, United States of America

P. Whitney Swain III

Affiliation Promiliad Biopharma Inc., Alberton, Montana, United States of America

Jeremy B. Alverson

Affiliation Promiliad Biopharma Inc., Alberton, Montana, United States of America

Nigel D. Priestley

Affiliation Promiliad Biopharma Inc., Alberton, Montana, United States of America

Amy C. Anderson

amy.anderson@uconn.edu (ACA) (AA); dennis.wright@uconn.edu (DLW) (DW)

Affiliation Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut, United States of America

Dennis L. Wright

amy.anderson@uconn.edu (ACA) (AA); dennis.wright@uconn.edu (DLW) (DW)

Affiliation Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut, United States of America

Competing Interests

Dr. Nigel Priestley is a co-founder of Promiliad Biopharma, Inc. The University of Connecticut has a patent pending that describes these compounds. BM, JA, WS are employees of Promiliad Biopharma. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: DW AA. Performed the experiments: KV KF ES BM PWS JA. Analyzed the data: KV KF ES BM PWS JA NP AA DW. Wrote the paper: AA DW KV.